The impact of oral nutritional supplementations (ONS) is not well-elucidated in children with stunting.
INTRODUCTION
Globally, stunting affected 151 million children under the age of 5 in 2017, with more than half of these children living in Asia [1] . In Vietnam, nearly 1 in 4 children under the age of 5 undernutrition as it leads to extensive health and socioeconomic consequences, including increased mortality and morbidity from infectious diseases as well as impaired cognitive, psychological and behavioral development in childhood and adolescence [8 -12] . In the long-term, stunting contributes to shorter adult height, lower attained schooling, reduced income and productivity, decreased offspring birth weight, and increased risk for the development of chronic disease [13 -16] .
Nutritional interventions for stunting aim to improve nutritional intake and provide all essential nutrients that are required to promote catch-up growth. To overcome stunting, energy intake must be optimized in conjunction with the intake of macronutrients, such as protein, and micronutrients, including zinc and vitamin A [17 -20] . Dietary counseling (DC) using family foods is one such strategy for addressing child malnutrition [21, 22] . However, several challenges may limit the effectiveness of a food-based approach in developing countries [23] . In Vietnam, family foods typically comprise of rice, legumes, oilseeds, vegetables, sugar, salt, and monosodium glutamate, which have high antinutrient content and low density in terms of macro-and micronutrients [7, 18, 24] . Furthermore, there is poor consumption of fruits, fish, and animal-based foods in Vietnam [7] . Another challenge of using DC to overcome stunting is that it requires dietary diversity [20] and may be difficult to implement considering the aforementioned issues related to food insecurity and diversity in Vietnam. Moreover, dietary recommendations for moderately stunted children are non-specific and this may limit their effectiveness for catch-up growth [21] .
Other strategies for addressing stunting have varying success. For example, fortified blended foods (corn-soy or wheat-soy blends) contain antinutrients, have inadequate micronutrients, and are deficient in milk [23, 25] . Additionally, supplementation with type II nutrients (protein and zinc, in particular) may positively affect linear growth while there is varying evidence on the impact of micronutrient supplementation on height [19, 26 -30] . Recent studies have also investigated small-quantity lipid-based nutrient supplements (LNS), a type of home fortification that delivers energy, protein, essential fatty acids and micronutrients in a food base, for overcoming undernutrition in infants. However, results with LNS have been variable as they do not seem to promote linear growth in all infant populations [30 -33] .
In this milieu, oral nutritional supplements (ONS), which are specially formulated to provide energy, macronutrients and micronutrients, have been shown to be effective for linear growth. In a randomized controlled trial (RCT) in preschool children with picky eating behavior and growth faltering (weight-for-height percentile <25 th percentile), the provision of ONS and DC for 3 months resulted in significant increases in weight-for-height, weight-for-age, and height-for-age percentiles compared with DC alone. ONS also significantly reduced the incidence of upper respiratory tract infections in these children [34] . Additionally, long-term intervention with ONS plus initial DC promoted longitudinal ponderal and linear growth in nutritionally-at risk children aged 36-48 months [35] . Long-term ONS with initial DC was also associated with improved dietary diversity as well as adequate dietary intake of nutrients over 48 weeks and did not interfere with the intake of family foods [36] . Even in the absence of DC, ONS improved height and weight in short and lean prepubertal healthy children, who did not frequently consume a well-balanced diet [37] .
While the benefits of short-term and long-term interventions with ONS for growth are well-established, the impact of ONS on physical growth in children with stunting is less clearly defined. In this context, we examined the efficacy of ONS on linear and ponderal growth in preschool children with stunting (height-for-age z-score [HAZ] < -2) and low weight-for-height z-score (WHZ < -1) in Vietnam.
MATERIALS AND METHODS

Study Design and Participants
We conducted a prospective, single-arm intervention study in Thai Binh province, Vietnam between September 2015 and June 2016. Children were recruited from a nutritional screening program in two preschools in the Tien Hai district of Thai Binh. Children attending these preschools were eligible for nutritional screening if they were 24-48 months of age at the time of screening and if their family provided consent for participating in the study. Based on the nutritional screening, children were eligible for inclusion in the study if they were 24-48 months old, had stunting (HAZ < -2), and were at nutritional risk (WHZ < -1). Children who had chronic diseases other than stunting, such as congenital malformation or severe acute illness, at the time of enrollment were excluded from the study.
The study was conducted in accordance with the ethical principles that have their origins in the Declaration of Helsinki. Written informed consent was obtained from each child's parents or legal guardian. The study protocol and relevant documentation were approved by the Institutional Review Board of the Thai Binh University of Medicine and Pharmacy.
Intervention
Eligible children received two servings of ONS every day for 6 months. The commercially available ONS (PediaSure®; Abbott Laboratories, Vietnam) provides 450 kcal, 13.5g protein, and ≥50% micronutrient requirements when taken twice daily. Study collaborators trained preschool teachers and mothers to prepare the ONS according to the label instructions. Under the teachers' supervision, children consumed the ONS in the classroom at snack times (i.e. between main meals) in the morning and the afternoon during 6 days of the week. Parents were instructed to provide ONS to the child on Sunday when children did not attend school.
Outcome Assessments
The primary outcome was the change in HAZ from baseline to 6 months of intervention. Other outcomes included the change in weight-for-age z-score (WAZ) and WHZ from baseline to 3-and 6 months and the change in weight and height from the baseline to 3 months and 6 months. Height-forage, weight-for-age, and weight-for-height were calculated as sex-age-specific z-scores based on the WHO Child Growth Standards [2] . Stunting was defined as HAZ < -2 SD, underweight was defined as WAZ < -2 SD, and wasting was defined as WHZ < -2 SD.
Additionally, we analyzed the prevalence of stunting, underweight, and wasting status at baseline and 6 months. We also examined the effects of several factors, including age, sex, baseline HAZ, and parental education on change in HAZ over the 6-month study period. Reports of adverse events (AEs) and serious AEs were collected over the study period.
Anthropometric Assessment
Anthropometric measurements were performed by research staff from the Nutrition and Food Safety Department of the Thai Binh University of Medicine and Pharmacy who were trained on standardized methods of conducting these measurements. Body weight was measured with light clothes and without shoes and jackets using an electronic weighing scale (Tanita Limited, Itabashi-Ku, Tokyo Japan) and recorded to the nearest 0.1 kg. Standing height was measured without shoes or hat using a portable measuring board provided by the National Institution of Nutrition, Vietnam and recorded to the nearest 0.1 cm. Weight and height were measured at baseline and at 3 and 6 months.
Compliance Assessment
Compliance with the ONS was assessed from the product intake records that teachers completed on a daily basis on the weekdays. Parents reported their child's intake during the weekend using these records. Compliance with the ONS was determined by calculating the percentage of actual product consumed. This percentage was obtained by dividing the number of servings that were consumed by the number of servings that were instructed to be consumed over the 6 month period.
Statistical Analyses
The sample size was estimated using the Hazard formula. A minimum sample size of 120 children was required to provide 90% power to detect a difference of 0.15 and 0.25 SD in the mean change in HAZ from baseline to 6 months. Based on an estimated attrition rate of 20% (24 children), 144 children needed to enroll in this study for adequate power.
All statistical analyses were performed on an evaluable analysis, using SAS version 9.04. Descriptive results, such as anthropometric measurements, were summarized by the mean, and SD or median and the interquartile range (IQR). Categorical variables were summarized by the number of subjects (n) and as a percentage (%). All continuous variables were checked for normality using Skewness and Kurtosis tests. Nonparametric tests, such as the Mann-Whitney U-test and the Wilcoxon signed-rank tests, were used to examine differences between two groups for continuous variables with non-normal distribution. Mixed-effect models were used to estimate the mean HAZ, WAZ, and WHZ over the study period, after adjustment for confounding factors such as the child's age, sex, baseline HAZ and parental education level. The McNemar's test was used to compare the prevalence of stunting, underweight and wasting at baseline and at 6 months of intervention. The Proc mixed procedure, controlled for confounding factors, was used to calculate the significance of factors associated with the change in HAZ over the 6-month study period.
RESULTS
Study Participants
Of the 800 children who underwent nutritional screening in 3 villages in the Tien Hai District, 140 were enrolled in this study. Of the 140 enrolled children, 19 did not complete the study due to the loss to follow-up or change of residence or missed study procedures. 121 children were, therefore, remained included in the evaluable population-based on treatment compliance and data completeness. Table 1 shows the baseline characteristics of children in the intent-to-treat population and their parents. The mean child age was 34.7 months and 49% were male. At baseline, males were heavier than females (p=0.002) while the mean height was similar between the sexes. Additionally, males had significantly higher HAZ (p=0.018) and lower WHZ (p=0.005) than females. WAZ was comparable between the sexes. With respect to parental characteristics, over 60% of mothers were educated up to a high school and/or university level. 
Change in Anthropometric Indices Over Time
We assessed longitudinal growth using anthropometric indices measuring linear and ponderal growth over time. Fig.  (1) shows the median change in height and weight of the examined population from baseline to 3 months and 6 months of intervention. There were significant height and weight gain from baseline to 3 months and 6 months; the increase in these parameters was similar across sexes (p<0.0001; Fig. (1) ). There was more height gain during the last 3 months of the intervention period (median change of 4.43 cm at 6 months; IQR3.9-6.2 cm) compared with the first 3 months (median change of 1.62 cm at 3 months; IQR 1.52-2.25 cm (Fig. 1a) . In contrast, weight steadily increased from baseline to 3 months (median change of 1.11 kg; IQR 0.91-1.40 kg) and 6 months (median change of 1.81 kg; IQR: 1.41-2.21 kg) ( Fig. 1b) . Fig. (2) depicts the growth outcomes of the examined population expressed using the WHO Child Growth Standards. In terms of linear growth, there was a significant increase in the median HAZ from baseline to 3 months (p<0.0001) and 6 months of intervention (p<0.0001). At 6 months, children receiving the ONS had a 0.25 (IQR 0.09 to 0.623) z-score catch-up in median HAZ. There was also a significant improvement in ponderal growth as WAZ and WHZ significantly increased after 3 months (p<0.0001 for WAZ and WHZ) and 6 months of treatment with the ONS (p<0.0001). As was the case with the median HAZ, the median WAZ and WHZ shifted towards the normal distribution (0 z-score), which represents the reference population of the WHO Child Growth Standards, over the study period. At 6 months, the median WAZ improved by 0.65 units and the median WHZ improved by 0.72 units. Fig. (3) shows the magnitude of stunting (HAZ < -2), underweight (WAZ < -2) and wasting (WHZ < -2) at baseline and 6 months of intervention with ONS in the examined population. There was a significant decrease in the prevalence of stunting at 6 months of intervention when approximately 40% of children recovered from stunting based on the HAZ (p<0.0001). Additionally, relative to baseline rates, the prevalence of underweight (p<0.0001) and wasting status (p=0.0310) were also significantly reduced at 6 months.
Prevalence of Stunting, Underweight, and Wasting Status
Factors Associated with a Change in HAZ Over 6 Months
Factors associated with a change in HAZ over the study period are shown in Table 2 . Over the 6 months, there was a significant increase in the HAZ of 0.06 units per month (p<0.0001). Additionally, baseline age and baseline HAZ were significantly associated with HAZ alteration, since young children displayed a greater increase in HAZ compared with older children. Each additional month of age was associated with a lower HAZ by 0.06 units at the end of the 6-month intervention (p<0.0001). Children who had 1.0-unit lower baseline HAZ had a small but significant increase in HAZ, resulting in smaller differences in their HAZ at 6 months with 0.94 units (p<0.001). In contrast, there was no association between sex and change in HAZ after 6 months of intervention. Similarly, parental education did not significantly affect the change in HAZ.
Compliance and Safety
All children in the examined population were reported to consume 75% of the recommended dose of the ONS on a daily basis. No AEs related to product consumption, including nausea, regurgitation, vomiting, flatulence, constipation or diarrhea, were reported during the intervention period.
DISCUSSION
In this study, we demonstrate that 6-month supplementation with ONS significantly improved linear and ponderal growth in preschool children with stunting and low WHZ. Additionally, ONS significantly reduced the prevalence of stunting as well as underweight and wasting status over the follow-up period.
Stunting is a dynamic process that reflects persistent or long-term malnutrition [17] . Reversing stunting requires accelerated or catch-up growth, which is a growth in height above the normal rate for an age that occurs after a period of growth retardation [38] . Unlike weight gain, which requires higher energy intake, catch-up linear growth requires increased energy as well as growth and functional nutrients in adequate amounts for the synthesis of skeletal and lean tissue [17, 18] . The ONS used in this study was composed of high-quality protein, easily-digested fat, carbohydrates, and all the essential micronutrients that are necessary for growth and physiological functions. The applied ONS provided 33% of the energy and approximately 50% of the recommended daily micronutrient and protein requirements for Vietnamese children aged 3-5 years. Therefore, the significant benefits of ONS observed in our study support the vital role of multiple nutrient intervention approaches using energy, macronutrients and micronutrients in reversing stunting.
In the present study, treatment of stunted children with ONS for 6 months significantly improved HAZ by 0.25 units, WHZ by 0.72 units, and WAZ by 0.65 units from baseline. Other studies have also shown significant improvements in linear and ponderal growth in non-stunted children after intervention with ONS [34, 35] . However, in some studies that used similar ONS in non-stunted children, there was no significant improvement in HAZ after ONS application, although there was a trend towards the improved height and HAZ in the intervention groups [39, 40] . This discrepancy may be attributed to the short study duration (3-4 months) , the difference in supplementation dosage, the degree of growth deficits, and whether the children receiving the ONS had acute illnesses, such as upper respiratory tract infections, at baseline. In our study, compared with the normal rate of height gain based on the WHO Child Growth Standards at the median values for height-for-age, catch-up growth in height was more evident during the last 3 months of ONS intervention (1.4 times the normal rate) versus the initial 3 months (0.9 times). In contrast, compared with the normal rate of weight gain, the rate of weight gain in the present study was faster during the first 3 months (1.8 times) of treatment with ONS than the last 3 months (1.2 times).
Similar to the growth improvements with ONS in our study, several RCTs have demonstrated the impact of supplementary feeding interventions in children with stunting. Relative to controls, provision of micronutrient-fortified milk for 1 year significantly improved mean HAZ (0.28 unit increase from baseline), WAZ (0.38 unit increase), and WHZ (0.42 unit increase) in children aged 1-4 years, of whom nearly two-thirds were either stunted or stunted and wasted [41] . Additionally, in an RCT involving children aged 25-48 months in the Thai Binh province, 12-month consumption of locallyavailable clam meat significantly improved mean HAZ (0.44 unit increase) relative to controls; stunting was reduced by 39% in children with stunting, who comprised 34% of the intervention group [42] . Comparatively, the ONS in our study resulted in a HAZ increase of 0.25 units, with similar levels of recovery from stunting (40%) after only 6 months of intervention. Another community-based RCT in 12-23-monthold Vietnamese children with stunting demonstrated that compared with DC alone, DC plus supplementary feeding using locally available foods significantly improves HAZ (0.60 unit increase) and stunting as 55% of the tested population was not classified as stunted at the end of the 12-month intervention period [43] . The increase in HAZ reported by Vu et al. is higher than the HAZ increase (0.25 units) in our study, possibly because the children in the study by Vu et al. were younger than that participated in our study and may have experienced a greater increase in HAZ due to their younger age. Additionally, while 55% of children in the study by Vu et al. recovered from stunting after 1 year of intervention, 40% of the children in our sample recovered from stunting after only 6 months of intervention with ONS. A Cochrane meta-analysis of RCTs that included a wide age range (3 months-5 years) of children demonstrated a small but significant effect of supplementary feeding with food and/or drink on WAZ and HAZ while WHZ was not affected [44] . However, this review concluded that while supplementary feeding interventions can work, these interventions fail to meet the initial expectations likely due to sub-optimal implementation.
Other interventions using single-or multiple micronutrient supplementation have also aimed to improve linear and ponderal growth in young children with nutritional deficits. However, the effect of these interventions on growth is variable. In an RCT conducted in 4-36-month-old Vietnamese children with stunting and underweight status, daily zinc supplementation (10 mg/day) for 5 months significantly improved mean HAZ (0.29 unit increase from baseline) and WAZ (0.18 unit increase from baseline) compared with placebo; the change in WHZ was not significantly different between the treatment and control groups [45] . Relative to our study, Ninh et al. reported a slightly higher HAZ increase with zinc supplementation, possibly due to the younger age of children in that study compared to that participated in our study. In contrast, other meta-analyses have found that zinc supplementation has a limited impact on growth parameters as well as stunting, underweight, and wasting status in children [46, 47] . There is also a controversy on the efficacy of multiple micronutrient supplementation for linear growth and stunting [19, 26, 28, 48] , with one review concluding that although multiple micronutrient interventions improve linear growth, the benefits are small [48] . Indeed, a meta-analysis in children ≥ 2 years of age who have experienced growth failure found that while single micronutrients (zinc, vitamin A), multiple micronutrients, and macronutrients (protein) significantly improve linear growth, protein supplementation had a larger effect size (mean difference [MD] 0.68) on linear growth than zinc (MD 0.15), vitamin A (MD 0.05), and multiple micronutrient sole supplementation (MD 0.26) [19] . In this context, multiple micronutrient interventions alone may not be sufficient to adequately overcome stunting as protein is an important macronutrient for linear growth [26, 30] . While the extent to which our results are comparable to those from other interventions is limited by differences in the study design and populations, the ONS in our study may offer a balanced combination of energy and nutrients (micro and macro) to support catch-up growth in children with stunting [35] .
In the current study, baseline HAZ and age were associated with the change in HAZ over 6 months. Children who were more severely stunted (lower HAZ) at baseline were more likely to experience improvement in HAZ during our study. This finding is consistent with another study that reported that catch-up growth in HAZ was twice as large in stunted children (aged 2-7 years) compared with marginally stunted children (−2≤ HAZ ≤ −1) [49] . Baseline HAZ has also been shown to be a significant inverse predictor of the effect of protein and micronutrient supplementation on height in children ≥ 2 years of age [19] . While younger children had a greater increase in HAZ compared with older children in the present study, a meta-analysis reported that baseline age did not significantly impact the effect of nutrition interventions on height in children ≥ 2 years of age [19] . In addition, unlike previous studies that have demonstrated the impact of parental education on height-for-age, this factor was not significantly associated with a change in HAZ in this study [50, 51] . This may be explained by the relative homogeneity of our study population, which was recruited from a single province in Vietnam, as well as the similar maternal education levels in our study.
Our study was conducted in children aged 24-48 months, which is beyond the 'first 1000 days' window. This window, from conception to 2 years of age, is widely recognized as the critical time for implementing nutritional interventions for stunting, with interventions outside this window considered unlikely to impact catch-up growth [8, 52] . However, several longitudinal studies have demonstrated that catch-up linear growth still occurs after the 'first 1000 days' [53, 54] . The Young Lives study, a 15-year longitudinal cohort study of childhood poverty in four low and middle-income countries in Ethiopia, India, Peru, and Vietnam, found that the incidence of recovery from stunting between ages 1 and 5 years ranges from 27% (Vietnam) to 53% (Ethiopia); between ages 5 and 8 years, it ranged from 30% (India) to 47% (Ethiopia). The results suggest that catch-up from stunting post-infancy is possible and nutritional interventions to improve stunting status should also be provided to stunted children after infancy and early childhood [53] . Furthermore, nutrition interventions using protein, single, or multiple micronutrients have been found to positively affect linear growth after 2 years of age [19] . Additionally, analyses of absolute height-for-age differences indicate that linear growth deficits accumulate beyond 2 years of age, as 70% of the absolute height deficit at 60 months can be attributed to faltering during the 'first 1000 days' whereas 30% is due to continued increases in the deficit from age 2-5 years [55] . In this context, our study suggests that nutritional intervention in stunted children older than 2 years is effective in promoting catch-up linear growth, which could potentially mitigate the adverse consequences of stunting. As even mild undernutrition is associated with increased mortality in children under 5 years of age, early intervention has been recommended as a preventive approach to mitigate nutrition deficits in children at risk of undernutrition [9, 23, 56] .
Our study had some limitations. This was a single-arm clinical trial with no control group; as such, the causal effects of the ONS intervention on growth parameters need to be further established in a placebo-controlled RCT. However, considering the well-established association between poor nutrition and impaired growth in children [57] as well as previous RCTs demonstrating the positive effect of ONS for growth [34, 40] , there is a high probability that the ONS contributed to improved growth in the current study. Another limitation is the lack of assessment of dietary intake as well as parental height as a proxy for genetic influences in the analysis of the factors associated with a change in HAZ over the followup period.
While the long-term effects of ONS on physical growth have been established in children at nutritional risk [35] , further studies evaluating the long-term impact of ONS on height and weight in children with stunting are warranted. Additionally, as overcoming chronic undernutrition requires an integrated approach, studies examining the efficacy of combining diet and supplementation for stunting could provide useful insights. In developing countries, assessing the costeffectiveness of nutritional interventions in children with stunting is likely to have important public health implications.
CONCLUSION
In conclusion, nutritional intervention with ONS appears to be beneficial for improving physical growth in stunted children at risk of wasting. Furthermore, the energy, macronutrients and micronutrients provided by this intervention have the potential to reduce stunting, underweight and wasting status in stunted children. 
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